- 9 million women in the US report recurrent yeast infections
- single dose led to reduced recurrences of vulvovaginal candidiasis
- will also study against Staphylococcus aureus... read more
Innovent Biologics, Inc., announced the completion of its US$150 million Series E round financing.
This round of financing attracted high quality global institutional investors and... read more
CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it received an Import Medical Device Market Approval from... read more
Eloxx Pharmaceuticals, Inc. (Nasdaq:ELOX) on 4/25/18 announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at a price to the public of $9.75 per share.... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,